Table 1.
General characteristics of the study population (n = 532)
| Variables | Mean ± SD | Median/range/percentages |
|---|---|---|
| Age (years) | 35.29 ± 14.70 | 32 (15–85) |
| Gender | ||
| Male | 377 | 70.9% |
| Female | 155 | 29.1% |
| Length of hospital stay | 3.46 ± 3.45 | 3 (1–33 days) |
| Peak creatinine (µmol/L) | 98.124 ± 83.98 | 79.56 (17.68–875.16) |
| Peak creatinine in AKI (µmol/L) | 229.84 ± 174.15 | 149.6 (114.92–875.16) |
| Admission creatinine (µmol/L) | 90.16 ± 61.88 | 79.56 (17.68–857.48) |
| Admission hematocrit (Proportion of 1.0) | 0.4102 ± 0.063 | 0.415 (0.199–0.58) |
| Peak hematocrit (Proportion of 1.0) | 0.422 ± 0.0563 | 0.424 (0.264–0.58) |
| Platelets | 38.65 ± 42.14 | 23 (2–427) |
| Alanine aminotransferase (µkat/L) | 2.73 ± 5.86 | 1.27 (0.050–60.55) |
| Prothrombin time (s) | 12.82 ± 8.70 | 11.10 (3–120) |
| aPTT (s) | 36.02 ± 15.12 | 33.35 (11.2–120) |
| Central nervous system involvement | 11 | 2.1% |
| Vasopressin | 5 | 0.9% |
| Respiratory failure | 14 | 2.6% |
| WHO classification | ||
| DF | 449 | 84.4% |
| DHF | 76 | 14.3% |
| DSS | 7 | 1.3% |
| Length of stay in hospital (days) | ||
| ≤3 | 386 | 72.6% |
| >3 | 146 | 27.4% |
| Alanine aminotransferase | ||
| Normal | 156 | 29.3% |
| Mild hepatitis 0.75–5.01 µkat/L | 329 | 61.8% |
| Severe hepatitis >5.01 µkat/L | 47 | 8.8% |
| Prothrombin time (s) | ||
| ≤15 | 468 | 88% |
| >15 | 64 | 12% |
| aPTT (s) | ||
| ≤35 | 307 | 57.7% |
| >35 | 225 | 42.3% |
| Platelets (per µL) | ||
| <50 000 | 406 | 76.3% |
| 50 000–100 000 | 93 | 17.5% |
| 100 000–150 000 | 23 | 4.3% |
| >150 000 | 10 | 1.9% |